Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma

Cancer Medicine
Di M JiangElena Elimova

Abstract

The goal of surveillance testing is to enable curative salvage therapy through early disease detection, however supporting evidence in gastroesophageal adenocarcinoma is limited. We evaluated frequency of successful salvage therapy and outcomes in patients who underwent surveillance. A single-site, retrospective cohort study was conducted to identify all patients who received curative resection for gastroesophageal adenocarcinoma. Surveillance testing were those investigations not triggered by abnormal symptoms, physical examination, or blood tests. Successful salvage therapy was any potentially curative therapy for disease recurrence which resulted in postrecurrence disease-free survival ≥2 years. Time-to-event data were analyzed using the Kaplan-Meier method and log rank tests. Between 2011 and 2016, 210 consecutive patients were reviewed. Esophageal (14%), gastroesophageal junction (40%), and gastric adenocarcinomas (45%) were treated with surgery alone (29%) or multimodality therapy (71%). Adjuvant therapy was administered in 35%. At median follow-up of 38.3 months, 5-year overall survival (OS) rate was 56%. Among 97 recurrences, 53% were surveillance-detected, and 46% were symptomatic. None was detected by surveillance end...Continue Reading

References

Jul 1, 1992·Medical Physics·M M Goodsitt, R H Johnson
May 31, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharlene GillEric M Yoshida
Oct 2, 2003·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Yutaka TakahashiUNKNOWN Tumor Marker Committee
Oct 7, 2003·Annals of Surgical Oncology·Yasuhiro KoderaAkimasa Nakao
Dec 2, 2004·Surgical Oncology·Erik M GrossmannRolando Fossati
Sep 27, 2005·Journal of the American College of Surgeons·Joseph J BennettDaniel G Coit
Jan 27, 2006·World Journal of Gastroenterology : WJG·Fabio CarboniEugenio Santoro
Mar 9, 2006·Annals of Surgical Oncology·Alice C WeiSteven Gallinger
Jul 11, 2006·The New England Journal of Medicine·David Cunningham MAGIC Trial Participants
Aug 8, 2007·Journal of Surgical Oncology·Ing Tuan Tan, Bok Yan Jimmy So
Apr 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C A ThompsonJ P Leonard
Mar 3, 2012·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Roberta CardosoSimron Singh
Jun 1, 2012·The New England Journal of Medicine·P van HagenUNKNOWN CROSS Group
Jan 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vera OppedijkMaarten C C M Hulshof
Jan 17, 2014·JAMA : the Journal of the American Medical Association·John N PrimroseUNKNOWN FACS Trial Investigators
Feb 15, 2014·Annals of Surgical Oncology·Gian Luca BaiocchiGiovanni De Manzoni
Apr 24, 2014·Journal of Gastrointestinal Cancer·Renata D PeixotoWinson Y Cheung
Aug 27, 2014·Journal of the American College of Surgeons·Gaya SpolveratoTimothy M Pawlik
Sep 19, 2014·World Journal of Gastroenterology : WJG·Gian Luca BaiocchiGiovanni De Manzoni
Jul 5, 2015·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Gian Luca BaiocchiGiovanni de Manzoni

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
biopsy
dissection

Software Mentioned

R
R Core Team

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.